Back
Aclaris Therapeutics 10K Form
Sell
26
ACRS
Aclaris Therapeutics
Last Price:
1.25
Seasonality Move:
-2.56%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ACRS News And Ratings
See the #1 stock for the next 7 days that we like better than ACRS
ACRS Financial Statistics
Sales & Book Value
Annual Sales: | $31.25M |
---|---|
Cash Flow: | $-7.2M |
Price / Cash Flow: | 0 |
Annual Sales: | $2.22 |
Price / Book: | 0.56 |
Profitability
EPS (TTM): | -1.27000 |
---|---|
Net Income (TTM): | $-88.48M |
Gross Margin: | $13.17M |
Return on Equity: | -50.99% |
Return on Assets: | -38.95% |
Aclaris Therapeutics Earnings Forecast
Key Aclaris Therapeutics Financial Ratios
- The Gross Profit Margin over the past 10 years for ACRS is 42.14%.
- The Selling, General & Administrative Expenses for ACRS have been equal to 99.52% of Gross Profit Margin.
- The Research & Development expenses have been 314.84% of Revenue.
- The Net Earning history of ACRS is -283.15% of Total Revenues.
- Per Share Earnings over the last 11 years have been positive in 5 years.
Aclaris Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | ACRS |
CUSIP: | 00461U |
Website: | aclaristx.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 4.16 |
Quick Ratio: | 3.86 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
ACRS Technical Analysis vs Fundamental Analysis
Sell
26
Aclaris Therapeutics (ACRS)
is a Sell
Is Aclaris Therapeutics a Buy or a Sell?
-
Aclaris Therapeutics stock is rated a Sell
The current Aclaris Therapeutics [ACRS] share price is $1.23. The Score for ACRS is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.